Pfs Partners, LLC Guardant Health, Inc. Transaction History
Pfs Partners, LLC
- $210 Billion
- Q3 2025
A detailed history of Pfs Partners, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Pfs Partners, LLC holds 330 shares of GH stock, worth $22,265. This represents 0.01% of its overall portfolio holdings.
Number of Shares
330Holding current value
$22,265% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
417Shares Held
126MCall Options Held
1.51MPut Options Held
2.35M-
Vanguard Group Inc Valley Forge, PA12.2MShares$821 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$758 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA4.98MShares$336 Million0.05% of portfolio
-
Baillie Gifford & CO4.81MShares$325 Million0.2% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.25MShares$287 Million7.85% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $6.9B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...